Ablation clinical trials at UCSD

1 research study open to eligible people

Showing trials for

  • Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

    open to eligible people ages 18-100

    This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM) device.

    San Diego, California and other locations

Our lead scientists for Ablation research studies include .

Last updated: